Hoth Therapeutics, Inc

Sumitovant Biopharma, Inc., based in New York, NY, is dedicated to improving global health by driving innovative treatments in critical areas such as psychiatry, neurology, oncology, urology, women's health, rare diseases, and cell gene therapy. Their diverse pipeline of preclinical and clinical programs aims to address high patient needs through a technology-driven approach. Sumitovant Biopharma, Inc., through its U.S. subsidiary, Sumitomo Pharma America, Inc., embodies a bold promise of combining technology and life-sciences expertise to deliver patient-first solutions faster and more efficiently, ultimately improving patient outcomes worldwide.Generated from the website

Q BioMed Inc. is a biotech acceleration and commercialization company based in New York, NY. They specialize in acquiring, developing, and financing undervalued biomedical assets in various therapeutic areas, with a focus on the biotechnology and healthcare sectors. Their strategic approach involves minimizing risk, sharing success, and accelerating technologies from incubation to monetization, ultimately aiming to provide public market access for private company assets. With expertise in business product development and capital formation, Q BioMed Inc. aims to bridge the gap for biomedical start-ups lacking capital and resources to transition from incubation to development and beyond. Their strategy revolves around maximizing risk-adjusted returns by focusing on value-driven assets, ranging from early-stage to near-revenue businesses, where technical, regulatory, and commercial risks have been mitigated or where major valuation inflections are imminent.Generated from the website

Turing Pharmaceuticals AG is a New York-based company that specializes in the development and distribution of pharmaceutical products. Their flagship product, VECAMYL, is an oral anti-hypertensive medication used for the management of moderately severe to severe essential hypertension and uncomplicated cases of malignant hypertension. The company offers a comprehensive support program, the VECAMYL Total Care Program, which provides patients with a single point of contact to address their needs related to obtaining VECAMYL. With a focus on patient safety, Turing Pharmaceuticals AG emphasizes the importance of consulting healthcare providers for medical advice and closely following prescribed treatment plans.Generated from the website